Next-generation sequencing strategies in venous thromboembolism: in whom and for what purpose?
This invited review follows the oral presentation “To Sequence or Not to Sequence, That Is Not the Question; But ‘When, Who, Which and What For?’ Is” given during the State of the Art session “Translational Genomics in Thrombosis: From OMICs to Clinics” of the International Society on Thrombosis and...
Saved in:
Published in | Journal of thrombosis and haemostasis Vol. 22; no. 7; pp. 1826 - 1834 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Inc
01.07.2024
Wiley |
Subjects | |
Online Access | Get full text |
ISSN | 1538-7836 1538-7933 1538-7836 |
DOI | 10.1016/j.jtha.2024.04.004 |
Cover
Summary: | This invited review follows the oral presentation “To Sequence or Not to Sequence, That Is Not the Question; But ‘When, Who, Which and What For?’ Is” given during the State of the Art session “Translational Genomics in Thrombosis: From OMICs to Clinics” of the International Society on Thrombosis and Haemostasis 2023 Congress. Emphasizing the power of next-generation sequencing technologies and the diverse strategies associated with DNA variant analysis, this review highlights the unresolved questions and challenges in their implementation both for the clinical diagnosis of venous thromboembolism and in translational research. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
ISSN: | 1538-7836 1538-7933 1538-7836 |
DOI: | 10.1016/j.jtha.2024.04.004 |